# Nonpolymer- and Polymer-Based Drug-Eluting Stents for Restenosis (ISAR-TEST-1)

> **NCT00140530** · PHASE4 · COMPLETED · sponsor: **Deutsches Herzzentrum Muenchen** · enrollment: 450 (actual)

## Conditions studied

- Coronary Disease

## Interventions

- **DEVICE:** Paclitaxel-eluting stent (Taxus)
- **DEVICE:** Rapamycin-eluting stent

## Key facts

- **NCT ID:** NCT00140530
- **Lead sponsor:** Deutsches Herzzentrum Muenchen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2008-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00140530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00140530, "Nonpolymer- and Polymer-Based Drug-Eluting Stents for Restenosis (ISAR-TEST-1)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00140530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*